Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer.

François Eisinger, D Stoppa-Lyonnet, Michel Longy, +7

PubMed

Tumor BiologyHistoprognostic GradeBreast OncologyOncologyCancer Pathology +13

Standardization of ¹⁸F-FDG–PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma

Elena Zamagni, Cristina Nanni, Luca Dozza, +22

Journal of Clinical Oncology

[89Zr]Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial

Brian Shuch, Allan J. Pantuck, Jean‐Christophe Bernhard, +19

The Lancet Oncology

Positron Emission TomographyUrologyEngineeringOncologic ImagingMedical Imaging +11

Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial

Roch Houot, Emmanuel Bachy, Guillaume Cartron, +26

Nature Medicine

Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials

Clément Bailly, Caroline Bodet‐Milin, S. Couespel, +4

PLoS ONE

Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials

Bastien Jamet, Ludivine Morvan, Cristina Nanni, +10

European Journal of Nuclear Medicine and Molecular Imaging

Hematological MalignancyPrognostic EvaluationTransplantationRandom Survival ForestHealth Sciences +7

Cannabis induced acute coronary syndrome in a young female

Clément Bailly, Olivier Merceron, Nadjib Hammoudi, +2

International Journal of Cardiology

Cannabis UseSubstance AbuseCardiovascular DiseaseMyocardial InfarctionAcute Coronary Syndrome +6

Results from phase 3 study of ⁸⁹Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma (ZIRCON).

Brian Shuch, Allan J. Pantuck, Jean‐Christophe Bernhard, +16

Journal of Clinical Oncology

Surgical OncologyOncologic ImagingPet-mriRenal PathologyRenal Masses +23

Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study

Yann Touchefeu, Clément Bailly, Éric Frampas, +15

European Journal of Nuclear Medicine and Molecular Imaging

Oncologic ImagingAnti-cea Bispecific AntibodyMedicineGallium-68-labelled Imp-288 PeptidePathology +8

Prognostic value of metabolic parameters and clinical impact of 18F-fluorocholine PET/CT in biochemical recurrent prostate cancer

Mathilde Colombié, L. Campion, Clément Bailly, +7

European Journal of Nuclear Medicine and Molecular Imaging

Positron Emission TomographyUrologyMetabolic ParametersMedicinePrognostic Value +6